NeuroFit’s tDCS Spreads to Hospitals Ahead of Non-Covered Status
AI TIMES ·
✦ AI Summary
According to AI TIMES, NeuroFit has supplied its personalized tDCS solution to 10 medical institutions in South Korea, and cumulative treatm…
According to AI TIMES, NeuroFit has supplied its personalized tDCS solution to 10 medical institutions in South Korea, and cumulative treatments reached 2,694 as of August. Starting October 1, the solution will be applied at South Korean medical institutions as a non-covered item, and the company expects this will expand adoption in clinical settings and improve patient access. The target patients are those with finger motor paralysis caused by stroke, and the solution is used alongside existing rehabilitation therapy. The company supplies software that determines stimulation sites and methods based on brain images, together with an electrical stimulation device. Its supply range has already expanded from tertiary general hospitals to convalescent rehabilitation hospitals, and its use in real-world clinical settings is also growing quickly. The policy change is drawing attention as a turning point for gauging whether the technology can move beyond validation and take root in clinical practice.
Perspective
The key point in this move is not just that the technology has shown its potential, but that it has entered the actual reimbursement system. If non-covered application and expansion across medical institutions reinforce each other, the barrier to adoption in the field could fall, creating a virtuous cycle in which accumulated usage experience drives further adoption. In the end, this issue is less about the expansion of a single company's supply than about whether AI-based treatment planning tools can rapidly establish themselves as standard clinical aids in rehabilitation.
This perspective is BizCrush's own commentary and is not part of the reporting by AI TIMES.
This article was produced with the help of an automated content generation algorithm.
Source: AI TIMES
View originalThis article was summarized and organized by BizCrush based on the original article from AI TIMES. For exact quotations and full details, please refer to the original article.